No abstract available
MeSH terms
-
Adalimumab
-
Antibodies, Anti-Idiotypic / blood
-
Antibodies, Anti-Idiotypic / genetics
-
Antibodies, Anti-Idiotypic / immunology*
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / immunology*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / immunology
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / drug therapy
-
Drug Therapy, Combination
-
Humans
-
Immunogenetic Phenomena / genetics
-
Immunogenetic Phenomena / immunology
-
Immunosuppressive Agents / therapeutic use
-
Immunotherapy / adverse effects*
-
Incidence
-
Methotrexate / therapeutic use
-
Risk Factors
-
Thromboembolism / epidemiology*
-
Thromboembolism / immunology
-
Thromboembolism / prevention & control*
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Immunosuppressive Agents
-
Tumor Necrosis Factor-alpha
-
Adalimumab
-
Methotrexate